Otros idiomas Galera Therapeutics, Inc.

Acciones

GRTX

US36338D1081

Tiempo real estimado Cboe BZX Otros sitios de cotización 20:30:02 03/05/2024			Varia. Cinco días.	Varia. 1 de enero.
0,195 ^USD	+0,72 %		+2,04 %	+30,61 %

28/03	Galera Therapeutics, Inc. presenta los resultados del ejercicio cerrado el 31 de diciembre de 2023	CI
28/03	Galera Therapeutics, Inc. informa de los resultados del cuarto trimestre finalizado el 31 de diciembre de 2023	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Galera Adopts Limited Duration Stockholder Rights Agreement	13:00
North American Morning Briefing : Powell Awaited -2-	03/04
Galera Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
Galera Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	28/03
Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updates	28/03
Galera Therapeutics : Failure to Satisfy Listing Rule - Form 8-K	27/03
North American Morning Briefing : Markets on Hold -2-	20/03
North American Morning Briefing : Stock Futures -2-	13/03
Galera Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Galera Reports Third Quarter 2023 Financial Results and Recent Corporate Updates	14/11
Galera Reports Third Quarter 2023 Financial Results and Recent Corporate Updates	14/11
Galera Therapeutics Announces Review of Strategic Alternatives	31/10/23
Galera Shares Halted After FDA Says Avasopasem Needs Additional Phase 3 Trial	31/10/23
Galera Therapeutics, Inc. Announces Receipt of Type A Meeting Minutes and Strategic Update	31/10/23
Galera Announces Receipt of Type A Meeting Minutes and Strategic Update	31/10/23
Galera Announces Receipt of Type A Meeting Minutes and Strategic Update	31/10/23
Galera Therapeutics : Failure to Satisfy Listing Rule - Form 8-K	22/09/23
Galera Schedules Type A Meeting with FDA to Discuss Next Steps for Avasopasem	18/09/23
Galera to Participate in the H.C. Wainwright 25th Annual Global Investment Conference	05/09/23
North American Morning Briefing : Treasury Yields -2-	17/08/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Galera Therapeutics, Inc.

Acciones

GRTX

US36338D1081

Otros idiomas

Filtros